Swiss Airtainer has developed an active temperature-controlled container for air transport of pharmaceutical products, utilizing IoT technology with 16 sensors for real-time tracking and solar power for energy efficiency. Each container reduces CO2 emissions by 48%, addressing the industry's need for sustainable logistics solutions while ensuring compliance with Good Distribution Practice.
Funding
Funding not disclosed
Founders
Product
Problem
The pharmaceutical industry faces challenges in maintaining temperature control during air transport, leading to potential spoilage and compliance issues. Traditional methods often rely on heavy containers and energy-intensive cooling systems, resulting in high CO2 emissions and operational costs.
Solution
Swiss Airtainer provides active temperature-controlled containers for the air transport of pharmaceutical products, integrating IoT technology and sustainable energy solutions. The containers utilize 16 sensors for real-time tracking and remote access, optimizing logistics routes and minimizing unnecessary journeys. By reducing the container's tare weight by 40% and incorporating solar panels for self-sustaining energy use, Swiss Airtainer significantly lowers fuel consumption and CO2 emissions. The system's dual independent heating and cooling ensures consistent performance within a specified temperature range, while adhering to Good Distribution Practice (GDP) standards.
Target Audience
The primary target audience includes pharmaceutical companies, air cargo carriers, and logistics providers seeking reliable, sustainable, and GDP-compliant temperature-controlled solutions for transporting sensitive pharmaceutical products.
Features
- Active temperature control with a range of -30°C to +50°C
- IoT integration with 16 sensors for real-time tracking and remote monitoring
- Solar-powered energy system for reduced reliance on conventional power sources
- Lightweight design, reducing tare weight by 40% to minimize fuel consumption
- Dual independent heating and cooling systems for redundancy and consistent performance
- GDP compliance, ensuring quality and safety in pharmaceutical logistics
- Remote access capabilities for optimized logistics and reduced unnecessary journeys